Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

Clinical trial NCT00259922 · COMPLETED

Trial details

NCT number: NCT00259922
Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bowel Dysfunction Constipation

Start date: 2005-08-01
Primary completion: 2006-06-01
Enrollment: 485

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.